Browsing Molecular Pathology by author "Cojocaru, Elena"

Now showing items 1-3 of 3

    • Clinical management and outcomes of primary ovarian leiomyosarcoma - Experience from a sarcoma specialist unit. 

      Cojocaru, E; Palahepitiva Gamage, G; Butler, J; Barton, DP; Thway, K; et al. (ELSEVIER SCIENCE INC, 2021-03-01)
      Ovarian sarcomas account for 1% of all ovarian malignancies and amongst these, primary ovarian leiomyosarcoma is the rarest subtype. Primary ovarian leiomyosarcoma has a very poor prognosis, with less than 20% of patients ...

    • Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft Tissue. 

      Cojocaru, E; Thway, K; Fisher, C; Messiou, C; Zaidi, S; et al. (INT INST ANTICANCER RESEARCH, 2020-12-01)
      BACKGROUND/AIM: Clear cell sarcoma (CCS) is an aggressive sarcoma subtype, resistant to conventional anthracycline-based chemotherapy and radiation. The diagnosis is often challenging due to similarities with malignant ...

    • Is the IDH Mutation a Good Target for Chondrosarcoma Treatment? 

      Cojocaru, E; Wilding, C; Engelman, B; Huang, P; Jones, RL (Springer Science and Business Media LLC, 2020-03-01)
      <jats:title>Abstract</jats:title><jats:p>Chondrosarcomas are rare cancers of bone that arise from the malignant transformation of cells of chondrocytic lineage. They are known to be resistant to systemic cytotoxic chemotherapy ...